chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart started racing within seconds faster than it ever has even for about two minutes. My whole chest was then in pain for about 20mins after. I also felt very dizzy, light headed and like I was going to throw up for several hours after.
After I administered the vaccines, the patient stated that she couldn't breath. She was very frantic and panicked and her face turned red. She screamed for an inhaler, but I told her we can administer Epi-pen. Once she received the dose she started breathing normal and felt better. Emergency services came and cleared her to go home. She didn't want to go to the ER. The patient came to pharmacy urging us to give her a high dose flu shot and pneumovax. The technician processed the vaccines. However, the system did not prompt or stop the tech from giving her these outside of her age restriction, as it used to in the past.
Headache arm where she recieved injection is sore. Narrative: Employee awoke with headache this morning at 0430. Employee has not taken any OTC meds for headache. Employee was instructed to take OTC acetaminophen/ibuprofen.
Inappropriate dose of vaccine administered; Accidental overdose; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered) and ACCIDENTAL OVERDOSE (Accidental overdose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 ml. On 26-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered) and ACCIDENTAL OVERDOSE (Accidental overdose). At the time of the report, INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered) and ACCIDENTAL OVERDOSE (Accidental overdose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment medication were provided. Reporter informed that 1 ml of vaccine was administered to 4 patients.
This is my first pregnancy. I had a normal ultrasound at my 8-week appointment, showing heartbeat and movement. My estimated delivery date was October 12, 2021. Four days after my second COVID shot, I had my 12-week checkup. They ran a urine test and asked me questions about my progress, all seemed normal. I wasn't exhibiting any side effects that would lead me to believe that I had miscarried. The OBGYN attempted to listen to the heartbeat but couldn't hear anything, so she wrote me a prescription to head over to the imaging site to get an ultrasound just in case. I drove there immediately and was given an ultrasound. They couldn't hear anything so we went ahead with a TVA. After approximately 45 minutes and no updates, the technician said that the results would be forwarded to my doctor and that they would reach out to me about the results. My doctor informed me that they could not hear a heartbeat and that I must have miscarried within the past couple days because the fetus length was as expected for 12-weeks of gestation. I am now scheduled for D&C on 4/5/21.
1 hour after vaccine given - had a 3 1/2 hour episode of high pitched, inconsolable crying.
This spontaneous report was received from a Registered Nurse, referring unspecified patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with an unspecified number of improperly stored doses PROQUAD for prophylaxis (lot number reported as M037010 with expiration date of 21-FEB-2018 and lot number L039268 with expiration date of 05-APR-2017) (strength, dosage schedule, route of administration and anatomical location were not reported). No concomitant medications were provided. No adverse effects were reported. The doses of the vaccine with lot number M037010 experienced a temperature excursion greater than -15 Celsius (C) degrees and less than  -10 C degrees range for 10 minutes. There was a previous temperature excursion with the same temperature range for 3 hours and 55 minutes. The doses of the vaccine with lot number L039268 experienced a temperature excursion greater than -15 C degrees and less than -10 C degrees for 10 minutes range and there was a previous temperature excursion with the same temperature range for 70 hours and 50 minutes and  another temperature excursion with a temperature greater than -10 C degrees and less than 8 C degrees for 16 hours and 40 minutes. The aforementioned temperature was identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA001699:
Post vax, the pt stated to her doctor that she experienced flu-like symptoms, chills, and diarrhea.
Near syncopal episode and hypotension.  Per patient: received the Covid 19 Moderna vaccine on 1/29/2021.  I waited there for 15 minutes and felt fine.  At 3:00pm I experienced a surge  of heat in my body and my blood pressure dropped to 76/38 - pulse 38.  I was  not able to stand.  My wife called 911 and the EMT's came and confirmed the low  blood pressure.  They took me to Hospital where Dr.  did extensive tests including blood, head CT, Chest Xray, forearm Xray.  None  of these tests revealed a reason for the drop in pressure. Dr.  said, "  well I suppose you can write this off to the vaccine'.  My blood pressure  returned to normal on its own, no medication was administered at the hospital.   The Blood pressure has returned to normal within the next 48 hours and
Patient reported that a couple hours after the shot, he began to feel bad and the symptoms kept getting worse. Symptoms reported included swelling in throat, swollen lymph glands, runny nose, watering and itchy eyes, bloodshot eyes, sores on roof of mouth. Patient went to emergency room and received treatment for allergic reaction and placed on steroids.
One week after receiving my first Moderna vaccine, I developed a rash and swelling at the injection site. The rash was about 6-8 inches across, and slightly itchy.  The site is swollen and warm to the touch. I've had the rash now for 3 days.
Patient is a 66 y.o. male who presents as a transfer to Hospital from an outside hospital for ICH.  Patient states around 1130 he was running on the treadmill and noticed sudden left-sided weakness and decrease in station.  He arrived outside hospital and was found to have left-sided hemibody weakness, left-sided decrease in station and a right gaze preference.  CT at outside hospital showed large ICH with 3 mm of midline shift and vasogenic edema. repeat scan was performed and showed 7 x 2 x 4 cm frontal parietal region hemorrhage. Patient is now in rehab and states he has left sided paralysis
developed a rash; shingles; This is a spontaneous report from a contactable physician. A 56-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as first dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporting physician reported that a friend (patient) received first Pfizer Covid vaccine. Few days later her friend developed a rash, sent pictures to doctor that appears by photos to possibly be shingles. The outcome of the events was unknown.   Follow-up attempts are not completed; information about lot/batch number cannot be obtained. No further information is expected.
Tonic seizure, a few minutes after Hepatitis A vaccine given. Seizure lasted about 1 minute then postictal. Given oxygen, transported to medical center by paramedics.
immed following vax pt exp black circle size of dime on rt arm. bruised. nausea, fever. treated w/ice pack on arm.
Urticarial rash on chest and back < 72 hrs after receiving FLUMIST. Pt also with sore throat, nasal congestion, body aches, fever.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 16-JUL-2013, the patient was vaccinated with (Oka/Merck) VARIVAX (dose strength and route was not reported) (lot # H0108796 and expiry date: 24-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting (Oka/Merck) VARIVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for (Oka/Merck) VARIVAX. This is one of the several reports from the same reporter. Additional information has been requested.
According to ER Report - (pt. not reachable), (L) axilla lymph swelling w/ associated pain, redness and sweats, (4 cm swelling), dime sized induration at injection site. (Treatment Cephalexin antibiotic started.)
Immediately after injection was applied Pt's arm became red to site appx'  2 inches across with a small dime size lump at center. Area red hot slight swelling and hot to touch.
Patient returned to pharmacy and stated that she was itchy. She took 5ml diphenhydramine and sat down while we called 911. She attempted to stand up and fell to floor. Attending pharmacist stated she felt clammy. Her skin was red at first and then she went pale. She vomited a dozen times.  The ambulance arrived and took her to the hospital.
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown. Not Provided          No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
This spontaneous case, initially received from other health professional on 27-Sep-2018, concerns a female patient of unspecified age. On 27-Sep-2018, the patient was administered FLUCELVAX QIVc (dose: 1 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252226 and expiry date: 31-May-2019) (explicitly coded as overdose). No adverse event was reported. The reporter assessed the case as non-serious. This case (201804159) was linked to case: 201804158 reported by same reporter. Non-significant follow-up received from the reporter on 03-Nov-2018: No new information was available regarding the patient's age and adverse events. Hence, no changes were done in the narrative.
16 days after vaccination developed bloody diarrhea that lasted for 1 week; 2 weeks later developed a UTI; Called a healthcare center and was prescribed MACROBID; still feeling achy with muscle pain.
Within minutes I had pin prick red dots on my right arm. We were at a drive through clinic waiting the 15 minutes in the parking lot before leaving and had the paramedic from the ambulance come look. I leaned into the seat to let my husband photograph my dots, and where my shoulder was leaning into the seat, I immediately had a smattering of red pin prick dots. They began showing on my left arm. We were advised to go to the ER. My hemoglobin was fine (though clotting factors were off), and he?d see a few reactions like that, so we were sent home.   I had diarrhea, abdominal pain, and severe nausea, but nothing scary or bad.   I woke to not being able to urinate, and that was followed with complete incontinence. I cannot control my bladder at all, cannot urinate on demand, and often don?t realize I?m urinating until I feel the warm gush.
a little pain in the shoulder; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (a little pain in the shoulder) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (a little pain in the shoulder). At the time of the report, ARTHRALGIA (a little pain in the shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
After receiving the vaccine, a few days later I had started to feel a tingling and numbness on the right side of my face. It starts with my right eye down to the middle of my chin all the way though my cheek, lip, and then my tongue. Initially it felt like there was a hair or feather touching my skin, nut nothing was ever there. Over time it got more and more numb. It felt like nothing in that area. It didn't affect my muscles because i could still move my cheek, neck, and jaw. When I would shave in the morning it would feel like I was scrapping my right cheek and it was painful. It eventually subsided as a numb feeling in my lip and the right side of my tongue.  Prior to receiving the vaccine, I wasn't sick or had any illnesses. I went to the dentist to see if I had a tooth in my mouth that was causing these feelings, but the x-rays showed nothing. Then I went to a neurologist and did more test. I haven't received a diagnosis for my condition yet.  None of the doctors can prove that it was because of the COVID-19 vaccine.
1014 7:30 PM nauseous, headache, fever 101, vomited at 11 PM. 10/15 7 AM - nauseous, achy.
Intense headache every day after shot. Headache gets worse when lying down. Throbbing and thumping.; Extreme pressure in the head.; Dose received: 3; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 32-year-old female patient received bnt162b2 (BNT162B2), administered in left arm, administration date 08Jan2022 at 09:00 (Lot number: FL3197) at the age of 32 years as dose 3 (booster), single for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medication included: NUVARING. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EN6207, Anatomical location: Left arm, Administration time: 16:00), administration date: 31Mar2021, when the patient was 31 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot number: EN0161, Anatomical location: Left arm, Administration time: 15:00), administration date: 29Apr2021, when the patient was 32 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 08Jan2022 at 09:00, outcome "unknown", described as "Dose received: 3"; HEADACHE (non-serious) with onset 09Jan2022 at 22:00, outcome "not recovered", described as "Intense headache every day after shot. Headache gets worse when lying down. Throbbing and thumping"; HEAD DISCOMFORT (non-serious) with onset 09Jan2022 at 22:00, outcome "not recovered", described as "Extreme pressure in the head". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache and head discomfort.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures taken as a result of headache and head discomfort included treatment with tylenol and ibuprofen.
Swelling and redness at injection site, dizziness, fatigue, body aches, chest pressure, difficulty breathing, nausea- currently lasting  almost 2 days
supposed to receive a dose of Menveo on 17Aug2023 but was inadvertently given a dose of Bexsero instead; This non-serious case was reported by a consumer via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received Men B NVS (Bexsero) (batch number G7KX2, expiry date 31-MAR-2024) for prophylaxis.   On 17-AUG-2023, the patient received the 1st dose of Bexsero. On 17-AUG-2023, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: supposed to receive a dose of Menveo on 17Aug2023 but was inadvertently given a dose of Bexsero instead).     The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-AUG-2023 Practice Manager reports the patient was supposed to receive a dose of Menveo on 17th August 2023 but was inadvertently given a dose of Bexsero instead which led to Wrong vaccine administered.  The patient had not previously had any Bexsero dosing.  The correct Menveo dosing has not yet been administered. the vaccine administration facility is the same as primary reporter. The reporter consented to follow up.
Initial and follow-up information has been received from a health professional concerning a 14 year old female who in "early" December 2006, was vaccinated with Gardasil. There was no concomitant medication. Subsequently in "early" December 2006, the patient experienced flu-like symptoms and pain for about 4 days after injection. The sought unspecified medical attention. No diagnostics were performed.  Subsequently, in "mid-December" the patient recovered from flu-like symptoms and pain for about 4 days after injection.  Additional information has been requested.
rash looked like flea bites, about 10 to 20 lesions; Initial information received on 30-Jun-2020 regarding an unsolicited valid non-serious case from the physician.  This case involves a 16-year-old female patient who experienced rash, which looked like flea bites, about 10 to 20 lesions (rash), while she received MENINGOCOCCAL VACCINE.  Medical history, concomitant medication, past medical treatment, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect MENINGOCOCCAL VACCINE produced by unknown manufacturer (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient developed non-serious rash which looked like flea bites, about 10 to 20 lesions (rash), (unknown latency) following the administration of MENINGOCOCCAL VACCINE.  Details of laboratory data were not reported.  Final diagnosis was rash.   It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome was not reported.  There will be no information available on the batch number for this case.
This spontaneous report was received from a licensed nurse practitioner refers to an unspecified number of patients of unknown age and gender. The nurse reported that unspecified number of improperly stored VARIVAX (Merck) 0.5 milliliter (ml) doses have been administered subcutaneously to unspecified number of patients on unspecified dates. The vaccine have been stored at -10C (Celsius) (above recommended temperature range in product information) since July 2013. No adverse effect reported. Follow up information has been received form a healthcare worker concerning a patient of unspecified age and gender. On 30-JUL-2013, the patient was vaccinated with a dose of VARIVAX (Merck) (lot # H018786, exp date: 15-OCT-2014) that had been stored at -10 C (Celsius) (above recommended temperature range in product information) since July 2013. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
patient developed a itchy rash on the back of his hands which then spread to his legs and back
1) Sharp pain in arm near elbow (left arm) the pain comes and goes. Pain scale 8-9 at times.  It has woken me up the last two nights.  Enough pain I can?t fall back asleep. 2) Tingling in index finger (left)  feels like hit funny bone 3) Muscle twitching ? tricep, area underneath arm, upper chest (left side) See phone videos
swelling around eyes especially under occurred w/in 1hr of vax;pt had been given food coloring-this could hvae been culprit;swelling gone by next AM p/cool compresses & DPH given;
This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a 66-year-old female patient who received BOOSTRIX (batch number YG7AY, expiry date 23rd March 2019). Co-suspect products included ZOSTAVAX (batch number M035147, expiry date 25th October 2017). Concomitant products included PREVNAR. On 13th December 2016, the patient received BOOSTRIX (intramuscular) 0.5 ml and ZOSTAVAX (subcutaneous). On 13th December 2016, less than a day after receiving BOOSTRIX, the patient experienced muscle pain. On an unknown date, the patient experienced limbs stiffness. The patient was treated with cyclobenzaprine, tramadol and NSAIDS (Non-Steroidal Anti-Inflammatory Agents). On an unknown date, the outcome of the muscle pain and limbs stiffness were not recovered/not resolved. The reporter considered the muscle pain and limbs stiffness to be possibly related to BOOSTRIX. Additional details were provided as follows: The patient received vaccines at pharmacy back. The patient received BOOSTRIX on left deltoid and ZOSTAVAX on left arm. The patient received PREVNAR (batch number: 202071, expiry date: January 2018) as concomitant medication on right deltoid. On an unknown date, less than a year after receiving BOOSTRIX, the patient experienced stiffness in left arm. The left arm was the only side where patient experienced all events. The patient visited physician and tried multiple medications of OTC (over the counter) non-steroidal anti-inflammatory drugs which didn't help. The reporter was transferred to Medical Information System.
2 hours after injection got nauseated, vomiting, and itching. Next day came into pharmacy, pharmacist called her primary physician and said to tell her to take BENADRYL.
This is the second Covid Vaccine I have gotten. I had J&J in March and had what I think were blood clots in my left foot and right thigh (sharp localized pain) also flared my joint pain for about 3 weeks. This shot was my booster. I got Pfizer in hopes of doing better. I did ok at the vaccination site, everyone was great, stayed the half hour. Went to bed got up went to work about 9 am, palpitations started racing pulse felt like a double dose of my EpiPen. I work in an acupuncturist clinic at university and a fellow practitioner fit me in their schedule acupuncture slowed my heart rate and it has only kicked up a little the day after. I also have all over joint and muscle pain continuing.
RASH, SWOLLEN ARM...UP TO TWICE THE NORMAL SIZE, 102.8 DEGREES TEMPERATURE, THUMPING PAIN.
Tension headache in the bridge of the nose leading to the head, mild loss of taste, and feelings of weakness in the body about 13 hours after the second shot. No noticeable side effects after the first shot other than soreness at the injection site.
Crying non-stop 7.5 hrs. Stopped walking x 2 days. Swelling on (R) leg. Rash on (L) leg. Ice was applied by parent.